Deep Track Capital, LP Intellia Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 4,950,000 shares of NTLA stock, worth $70.8 Million. This represents 3.75% of its overall portfolio holdings.
Number of Shares
4,950,000
Previous 4,800,000
3.13%
Holding current value
$70.8 Million
Previous $107 Million
5.31%
% of portfolio
3.75%
Previous 3.53%
Shares
9 transactions
Others Institutions Holding NTLA
# of Institutions
313Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$175 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$138 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$137 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$73.6 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$45 Million0.05% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.09B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...